Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Prospects for treatment of latent HIV.

Barton KM, Burch BD, Soriano-Sarabia N, Margolis DM.

Clin Pharmacol Ther. 2013 Jan;93(1):46-56. doi: 10.1038/clpt.2012.202. Epub 2012 Oct 10. Review. Erratum in: Clin Pharmacol Ther. 2013 Apr;93(4):366.

2.

Regulation of human immunodeficiency virus-1 latency and its reactivation.

Verdin E.

Bull Mem Acad R Med Belg. 2008;163(6):355-64; discussion 364-5.

PMID:
19445107
3.

Epigenetic regulation of HIV-1 persistence and evolving strategies for virus eradication.

Dhamija N, Rawat P, Mitra D.

Subcell Biochem. 2013;61:479-505. doi: 10.1007/978-94-007-4525-4_21. Review.

PMID:
23150264
4.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
5.

HIV cure: knocking on the door.

Durand CM, Flexner C.

Clin Pharmacol Ther. 2013 May;93(5):382-4. doi: 10.1038/clpt.2013.22.

PMID:
23598454
6.

Latency reversal and viral clearance to cure HIV-1.

Margolis DM, Garcia JV, Hazuda DJ, Haynes BF.

Science. 2016 Jul 22;353(6297):aaf6517. doi: 10.1126/science.aaf6517. Review.

7.

[HIV eradication--facts and fiction].

Jaeger H, Wolf E.

MMW Fortschr Med. 2008 Apr 28;150 Spec No 1:72-3. German. No abstract available.

PMID:
19024923
8.

HIV-1 Reservoirs During Suppressive Therapy.

Barton K, Winckelmann A, Palmer S.

Trends Microbiol. 2016 May;24(5):345-55. doi: 10.1016/j.tim.2016.01.006. Epub 2016 Feb 12. Review.

9.

From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.

Shan L, Siliciano RF.

Bioessays. 2013 Jun;35(6):544-52. doi: 10.1002/bies.201200170. Epub 2013 Apr 24. Review.

10.

Review: Influence of ART on HIV genetics.

Simonetti FR, Kearney MF.

Curr Opin HIV AIDS. 2015 Jan;10(1):49-54. doi: 10.1097/COH.0000000000000120. Review.

11.

Targeting viral reservoirs: ability of antiretroviral therapy to stop viral replication.

Maldarelli F.

Curr Opin HIV AIDS. 2011 Jan;6(1):49-56. doi: 10.1097/COH.0b013e32834134ea. Review.

PMID:
21228755
12.

Therapeutics for HIV-1 reactivation from latency.

Sgarbanti M, Battistini A.

Curr Opin Virol. 2013 Aug;3(4):394-401. doi: 10.1016/j.coviro.2013.06.001. Epub 2013 Jun 28. Review.

PMID:
23810462
13.

Eradication therapies for HIV Infection: time to begin again.

Margolis DM.

AIDS Res Hum Retroviruses. 2011 Apr;27(4):347-53. doi: 10.1089/aid.2011.0017. Epub 2011 Mar 11. Review.

14.

Impact of Antiretroviral Therapy on HIV-1 Persistence: The Case for Early Initiation.

Hong FF, Mellors JW.

AIDS Rev. 2015 Apr-Jun;17(2):71-82. Review.

PMID:
26035165
15.

Didehydro-Cortistatin A: a new player in HIV-therapy?

Mousseau G, Valente ST.

Expert Rev Anti Infect Ther. 2016;14(2):145-8. doi: 10.1586/14787210.2016.1122525. Epub 2015 Dec 11.

16.

[Is it possible to cure HIV infection?].

Gutiérrez C, Madrid NP, Moreno S.

Rev Esp Quimioter. 2015 Sep;28 Suppl 1:54-6. Review. Spanish.

17.

[Antiretroviral therapy in 2004].

Jablonowski H.

MMW Fortschr Med. 2004 Apr 26;146 Spec No 1:46-8, 50-1. German.

PMID:
15373049
18.

HIV cure research: advances and prospects.

Passaes CP, Sáez-Cirión A.

Virology. 2014 Apr;454-455:340-52. doi: 10.1016/j.virol.2014.02.021. Epub 2014 Mar 11. Review.

19.

Landscape review of current HIV 'kick and kill' cure research - some kicking, not enough killing.

Thorlund K, Horwitz MS, Fife BT, Lester R, Cameron DW.

BMC Infect Dis. 2017 Aug 29;17(1):595. doi: 10.1186/s12879-017-2683-3. Review.

20.

The development of immune-modulating compounds to disrupt HIV latency.

Remoli AL, Marsili G, Battistini A, Sgarbanti M.

Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):159-72. doi: 10.1016/j.cytogfr.2012.05.003. Epub 2012 Jul 4. Review.

PMID:
22766356

Supplemental Content

Support Center